Xenon Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Burnaby
SEC filing record 1 source field available
Fiscal year end
31 December
Xenon Pharmaceuticals Inc. has filed 790 SEC EDGAR filings since 16 Aug 2013

SEC filing history

Showing 501-525 of 790 matching filings.

Per page
25
Current page
21
DEF 14A File 001-36687

DEF 14A

Filing date
27 Apr 2018
Reporting date
27 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36687

CT ORDER filing

Filing date
18 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
29 Mar 2018
Reporting date
27 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88403

AMENDMENT NO. 6 TO THE SCHEDULE 13G

Filing date
29 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36687

8-K

Filing date
28 Mar 2018
Reporting date
23 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Mar 2018
Reporting date
19 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 AYCARDI-FONSECA

Filing date
20 Mar 2018
Reporting date
19 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SHERRINGTON

Filing date
16 Mar 2018
Reporting date
15 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 HOLLER

Filing date
16 Mar 2018
Reporting date
14 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36687

8-K

Filing date
15 Mar 2018
Reporting date
15 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36687

8-K

Filing date
13 Mar 2018
Reporting date
13 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-223497

S-8

Filing date
07 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36687

8-K

Filing date
07 Mar 2018
Reporting date
07 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36687

8-K

Filing date
07 Mar 2018
Reporting date
07 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
01 Mar 2018
Reporting date
22 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Feb 2018
Reporting date
12 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88403

AMENDMENT NO. 5 TO THE SCHEDULE 13G

Filing date
14 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88403

SC 13G/A

Filing date
14 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .